Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (19)

2024

  1. Modulation of the K/BxN arthritis mouse model and the effector functions of human fibroblast-like synoviocytes by liver X receptors

    European Journal of Immunology

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review

    Rheumatology International, Vol. 39, Núm. 1, pp. 47-58

  2. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2015

  1. NSAIDs: Learning new tricks from old drugs

    European Journal of Immunology, Vol. 45, Núm. 3, pp. 679-686

2013

  1. Superoxide anion mediates the L-selectin down-regulation induced by non-steroidal anti-inflammatory drugs in human neutrophils

    Biochemical Pharmacology, Vol. 85, Núm. 2, pp. 245-256

2011

  1. No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis

    Clinical and Experimental Rheumatology

  2. The metalloprotease ADAM8 is associated with and regulates the function of the adhesion receptor PSGL-1 through ERM proteins

    European Journal of Immunology, Vol. 41, Núm. 12, pp. 3436-3442

2007

  1. Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding

    Journal of Immunology, Vol. 178, Núm. 12, pp. 8053-8063

2006

  1. The role of CD69 in acute neutrophil-mediated inflammation

    European Journal of Immunology, Vol. 36, Núm. 10, pp. 2632-2638

2002

  1. Structure-function relationship and role of tumor necrosis factor-α-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs

    Journal of Biological Chemistry, Vol. 277, Núm. 41, pp. 38212-38221

1999

  1. Prevention of αIIbβ3 activation by non-steroidal antiinflammatory drugs

    FEBS Letters, Vol. 446, Núm. 2-3, pp. 318-322

1998

  1. Inhibition of leukocyte adhesion: An alternative mechanism of action for anti-inflammatory drugs

    Immunology Today, Vol. 19, Núm. 4, pp. 169-172

  2. Interference of nonsteroidal antiinflammatory drugs with very late activation antigen 4/ vascular cell adhesion molecule 1-mediated lymphocyte- endothelial cell adhesion

    Arthritis and Rheumatism, Vol. 41, Núm. 9, pp. 1677-1688

1997

  1. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family

    Arthritis and Rheumatism, Vol. 40, Núm. 1, pp. 143-153

1995

  1. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs

    Journal of Clinical Investigation, Vol. 95, Núm. 4, pp. 1756-1765

1994

  1. Adhesion molecules from the LFA‐1/ICAM‐1, 3 and VLA‐4/VCAM‐1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands

    European Journal of Immunology, Vol. 24, Núm. 10, pp. 2483-2490

  2. Expression of L‐Selectin, CD43, and CD44 in Synovial Fluid Neutrophils from Patients with Inflammatory Joint Diseases

    Arthritis & Rheumatism, Vol. 37, Núm. 3, pp. 342-348

1990

  1. Integrins: the importance of cell adhesion

    Medicina clínica, Vol. 95, Núm. 16, pp. 630-635